Using the quantitative methylation-specific PCR (qMSP), Dubrowinskaja et al. found that the NEFH promoter was methylated both in RCC cell lines, with relative methylation >25% in two of six cell lines and in cancerous tissues compared to the paired normal specimens [19]. The gene discussed is NEFH; the disease is renal cell adenocarcinoma.